PGR stock news
This page provides real-time market news, earnings updates, and company announcements related to Progressive Corporation (The) (PGR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 07:07 EST
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
Finviz2026-04-01 11:06:41
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
Finviz2026-04-01 21:15:48
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Finviz2026-04-02 12:33:48
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst (bumetanide nasal spray)
Finviz2026-04-02 20:03:43
Minerva Announces Leadership Transition
Finviz2026-04-02 20:09:52
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-06 11:03:55
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
Finviz2026-04-06 13:21:42
OpenAI Releases 13-Page Policy White Paper Proposing Robot Tax, Universal AI Wealth Fund, and Four-Day Workweek
Cointime2026-04-07 02:19:09
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Finviz2026-04-07 11:03:42
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
Finviz2026-04-07 11:03:42
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
Finviz2026-04-07 11:33:10
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Finviz2026-04-07 11:33:11
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
Finviz2026-04-07 12:03:47
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ in Pediatric Malignant Gliomas
Finviz2026-04-08 11:33:11
China’s Alibaba deploys 10,000 homegrown chips as Big Tech plots Nvidia exit
Cryptopolitan2026-04-09 08:21:12
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Finviz2026-04-09 12:03:52
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
Finviz2026-04-14 11:03:54
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS
Finviz2026-04-14 11:03:55
NextPlat's GTC Receives Satellite Enabled Internet of Things (IoT) Contracts Valued at $400,000 as its Government and Military Pipeline Surpasses $1.2 Million Through Q1 2026
Finviz2026-04-14 11:48:08
Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation
Finviz2026-04-14 13:18:42
Minerva Announces Leadership Transition
Finviz2026-04-02 20:09:52
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-06 11:03:55
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Finviz2026-04-06 13:03:55
NeuroSense Granted Brazilian Patent Covering PrimeC Composition
Finviz2026-04-06 13:21:42
OpenAI Releases 13-Page Policy White Paper Proposing Robot Tax, Universal AI Wealth Fund, and Four-Day Workweek
Cointime2026-04-07 02:19:09
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
Finviz2026-04-07 11:03:42
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
Finviz2026-04-07 11:03:42
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
Finviz2026-04-07 11:33:10
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Finviz2026-04-07 11:33:11
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
Finviz2026-04-07 12:03:47
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ in Pediatric Malignant Gliomas
Finviz2026-04-08 11:33:11
China’s Alibaba deploys 10,000 homegrown chips as Big Tech plots Nvidia exit
Cryptopolitan2026-04-09 08:21:12
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
Finviz2026-04-09 12:03:52
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
Finviz2026-04-14 11:03:54
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI (sparsentan) in FSGS
Finviz2026-04-14 11:03:55
NextPlat's GTC Receives Satellite Enabled Internet of Things (IoT) Contracts Valued at $400,000 as its Government and Military Pipeline Surpasses $1.2 Million Through Q1 2026
Finviz2026-04-14 11:48:08
Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation
Finviz2026-04-14 13:18:42
PGR stock chart
PGR stock detailsPGR stock price change
On the last trading day, PGR stock closed at 199.57 USD, with a price change of 2.80% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more